[{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++BCS02-01 Artificial intelligence and machine\/deep learning,,"},{"Key":"Keywords","Value":"Deep learning,Tumor infiltrating lymphocytes,Survival,Microsatellite instability,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>S. B. Gruber<\/b><sup>1<\/sup>, O. S. M. El Nahhas<sup>2<\/sup>, J. D. Bonner<sup>1<\/sup>, J. K. Greenson<sup>3<\/sup>, D. Schmolze<sup>1<\/sup>, L. Shaktah<sup>1<\/sup>, J. Salazar<sup>1<\/sup>, L. Reynaga<sup>1<\/sup>, S. Lindsey<sup>1<\/sup>, J. Lu<sup>1<\/sup>, A. Mao<sup>1<\/sup>, V. Moreno<sup>4<\/sup>, S. L. Schmit<sup>5<\/sup>, Y.-Y. Tsai<sup>5<\/sup>, S. R. Hamilton<sup>1<\/sup>, G. Rennert<sup>6<\/sup>, J. N. Kather<sup>2<\/sup>; <br\/><sup>1<\/sup>City of Hope National Medical Center, Los Angeles, CA, <sup>2<\/sup>Technical University Dresden, Dresden, Germany, <sup>3<\/sup>University of Michigan, Ann Arbor, MI, <sup>4<\/sup>Catalan Institute of Oncology (ICO), Hospitalet de Llobregat, Spain, <sup>5<\/sup>Cleveland Clinic, Cleveland, OH, <sup>6<\/sup>Technion University, Haifa, Israel","CSlideId":"","ControlKey":"a6add2eb-82c1-49d8-95d4-3ed0637fc0ef","ControlNumber":"10485","DisclosureBlock":"<b>&nbsp;S. B. Gruber, <\/b> <br><b>Brogent International LLC<\/b> Other, Co-founder with equity. <br><b>O. S. M. El Nahhas, <\/b> <br><b>StratifAI<\/b> Other, Chief Executive Officer. <br><b>J. D. Bonner, <\/b> <br><b>Brogent International, LLC<\/b> Independent Contractor.<br><b>J. K. Greenson, <\/b> None..<br><b>D. Schmolze, <\/b> None..<br><b>L. Shaktah, <\/b> None..<br><b>J. Salazar, <\/b> None..<br><b>L. Reynaga, <\/b> None..<br><b>S. Lindsey, <\/b> None..<br><b>J. Lu, <\/b> None..<br><b>A. Mao, <\/b> None..<br><b>V. Moreno, <\/b> None..<br><b>S. L. Schmit, <\/b> None..<br><b>Y. Tsai, <\/b> None..<br><b>S. R. Hamilton, <\/b> None..<br><b>G. Rennert, <\/b> None.&nbsp;<br><b>J. N. Kather, <\/b> <br><b>StratifAI<\/b> Employment, Chief Scientific Officer.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10349","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"1","PosterboardNumber":"1","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB384","PresenterBiography":null,"PresenterDisplayName":"Stephen Gruber, MD;MPH;PhD","PresenterKey":"31776595-6202-40c6-9064-4b4ac04ec99b","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB384. Artificial intelligence measures of tumor infiltrating lymphocytes predict colorectal cancer-specific and overall survival","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"592","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Bioinformatics, Computational Biology, Systems Biology, and Convergent Science 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Artificial intelligence measures of tumor infiltrating lymphocytes predict colorectal cancer-specific and overall survival","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++BCS02-01 Artificial intelligence and machine\/deep learning,,"},{"Key":"Keywords","Value":"Deep learning,Tumor infiltrating lymphocytes,Biomarkers,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>O. S. M. El Nahhas<\/b><sup>1<\/sup>, J. D. Bonner<sup>2<\/sup>, J. K. Greenson<sup>3<\/sup>, D. B. Schmolze<sup>2<\/sup>, L. Shaktah<sup>2<\/sup>, J. Salazar<sup>2<\/sup>, L. Reynaga<sup>2<\/sup>, S. Lindsey<sup>2<\/sup>, J. Lu<sup>2<\/sup>, V. Moreno<sup>4<\/sup>, S. L. Schmit<sup>5<\/sup>, Y.-Y. Tsai<sup>5<\/sup>, S. R. Hamilton<sup>2<\/sup>, G. Rennert<sup>6<\/sup>, J. N. Kather<sup>1<\/sup>, S. B. Gruber<sup>2<\/sup>; <br\/><sup>1<\/sup>Technical University of Dresden, Dresden, Germany, <sup>2<\/sup>City of Hope National Medical Center, Los Angeles, CA, <sup>3<\/sup>University of Michigan, Ann Arbor, MI, <sup>4<\/sup>Catalan Institute of Oncology, Hospitalet de Llobregat, Spain, <sup>5<\/sup>Cleveland Clinic, Cleveland, OH, <sup>6<\/sup>Technion University, Haifa, Israel","CSlideId":"","ControlKey":"4d215788-1455-42df-973b-a85b526acbb0","ControlNumber":"10820","DisclosureBlock":"<b>&nbsp;O. S. M. El Nahhas, <\/b> <br><b>StratifAI<\/b> Other, Chief Executive Officer. <br><b>J. D. Bonner, <\/b> <br><b>Brogent International LLC<\/b> Independent Contractor.<br><b>J. K. Greenson, <\/b> None..<br><b>D. B. Schmolze, <\/b> None..<br><b>L. Shaktah, <\/b> None..<br><b>J. Salazar, <\/b> None..<br><b>L. Reynaga, <\/b> None..<br><b>S. Lindsey, <\/b> None..<br><b>J. Lu, <\/b> None..<br><b>V. Moreno, <\/b> None..<br><b>S. L. Schmit, <\/b> None..<br><b>Y. Tsai, <\/b> None..<br><b>S. R. Hamilton, <\/b> None..<br><b>G. Rennert, <\/b> None.&nbsp;<br><b>J. N. Kather, <\/b> <br><b>StratifAI<\/b> Chief Scientific Officer. <br><b>S. B. Gruber, <\/b> <br><b>Brogent International LLC<\/b> Other, Co-founder with equity.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10351","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"2","PosterboardNumber":"3","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB386","PresenterBiography":null,"PresenterDisplayName":"Omar El Nahhas, BS;MS","PresenterKey":"e24ef8f5-900c-44f3-8459-3644cfcb81ab","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB386. Weakly-supervised prediction of tumor infiltrating lymphocytes per high power field from colorectal cancer histopathology slides using regression transformers","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"592","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Bioinformatics, Computational Biology, Systems Biology, and Convergent Science 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Weakly-supervised prediction of tumor infiltrating lymphocytes per high power field from colorectal cancer histopathology slides using regression transformers","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++BCS02-01 Artificial intelligence and machine\/deep learning,,"},{"Key":"Keywords","Value":"In vitro,Tumor neovasculature,Deep learning,Preclinical testing,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>J. Ko<\/b><sup>1<\/sup>, N. Jeon<sup>2<\/sup>, Y. Oh<sup>2<\/sup>; <br\/><sup>1<\/sup>Gachon University, Seongnam-si, Korea, Republic of, <sup>2<\/sup>Seoul National University, Seoul, Korea, Republic of","CSlideId":"","ControlKey":"11104373-0452-4768-b98d-b5ba35809439","ControlNumber":"10587","DisclosureBlock":"&nbsp;<b>J. Ko, <\/b> None.&nbsp;<br><b>N. Jeon, <\/b> <br><b>Qureator, Inc.<\/b> Stock.<br><b>Y. Oh, <\/b> None.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10352","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"3","PosterboardNumber":"4","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB387","PresenterBiography":null,"PresenterDisplayName":"Jihoon Ko","PresenterKey":"7e338986-d871-40dc-a71e-23e61f372a0c","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB387. Microphysiological modeling of gastric cancer vasculature using iPSC-derived endothelial cells","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"592","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Bioinformatics, Computational Biology, Systems Biology, and Convergent Science 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Microphysiological modeling of gastric cancer vasculature using iPSC-derived endothelial cells","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++BCS02-01 Artificial intelligence and machine\/deep learning,,"},{"Key":"Keywords","Value":"Tyrosine kinase inhibitor,Solid tumors,Drug resistance,Deep learning,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>L. Xing<\/b>, J. Wang, W. Zhu; <br\/>LexBio, Suzhou, China","CSlideId":"","ControlKey":"d25e918b-248f-4b4a-ae2c-3bc695305d8d","ControlNumber":"9830","DisclosureBlock":"&nbsp;<b>L. Xing, <\/b> None..<br><b>J. Wang, <\/b> None..<br><b>W. Zhu, <\/b> None.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10353","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"4","PosterboardNumber":"5","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB388","PresenterBiography":"","PresenterDisplayName":"Li Xing, PhD","PresenterKey":"20ddc5ea-064c-4f5b-b29a-b3c6377a889c","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB388. Super potent and efficacious ALK\/ROS1\/TRK inhibitor that overcomes multiple drug-resistant mutations","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"592","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Bioinformatics, Computational Biology, Systems Biology, and Convergent Science 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Super potent and efficacious ALK\/ROS1\/TRK inhibitor that overcomes multiple drug-resistant mutations","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++BCS02-01 Artificial intelligence and machine\/deep learning,,"},{"Key":"Keywords","Value":"RET,Solid tumors,Drug resistance,Deep learning,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>L. Xing<\/b>, W. Zhu, J. Wang; <br\/>LexBio Therapeutics, Suzhou, China","CSlideId":"","ControlKey":"00154acc-80c4-461f-b7d6-bc3761aaa77b","ControlNumber":"10284","DisclosureBlock":"&nbsp;<b>L. Xing, <\/b> None..<br><b>W. Zhu, <\/b> None..<br><b>J. Wang, <\/b> None.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10354","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"5","PosterboardNumber":"6","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB389","PresenterBiography":"","PresenterDisplayName":"Li Xing, PhD","PresenterKey":"20ddc5ea-064c-4f5b-b29a-b3c6377a889c","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB389. Highly potent and selective RET inhibitor with robust anti-tumor activities against wild-type and acquired drug-resistant mutations","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"592","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Bioinformatics, Computational Biology, Systems Biology, and Convergent Science 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Highly potent and selective RET inhibitor with robust anti-tumor activities against wild-type and acquired drug-resistant mutations","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++BCS02-02 Digital pathology,,"},{"Key":"Keywords","Value":"Diagnostic marker,Prostate cancer,Deep learning,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>J. Vergara Cobos<\/b><sup>1<\/sup>, F. Carrillo-Perez<sup>2<\/sup>, M. Pizurica<sup>2<\/sup>, N. Andor<sup>3<\/sup>, O. Gevaert<sup>2<\/sup>; <br\/><sup>1<\/sup>Stanford University School of Medicine, Palo Alto, CA, <sup>2<\/sup>Stanford University, Palo Alto, CA, <sup>3<\/sup>Moffitt Cancer Center, Tampa, FL","CSlideId":"","ControlKey":"db9e1d43-21f8-422d-8179-19ab11115339","ControlNumber":"10717","DisclosureBlock":"&nbsp;<b>J. Vergara Cobos, <\/b> None..<br><b>F. Carrillo-Perez, <\/b> None..<br><b>M. Pizurica, <\/b> None..<br><b>N. Andor, <\/b> None..<br><b>O. Gevaert, <\/b> None.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10355","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"6","PosterboardNumber":"7","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB390","PresenterBiography":null,"PresenterDisplayName":"Josselyn Sofia Vergara Cobos","PresenterKey":"d2f43036-4f16-4a7c-b95f-9ad730ed2517","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB390. Enhancing prostate cancer diagnosis: A deep learning approach for DNA ploidy prediction from whole slide images","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"592","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Bioinformatics, Computational Biology, Systems Biology, and Convergent Science 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Enhancing prostate cancer diagnosis: A deep learning approach for DNA ploidy prediction from whole slide images","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++BCS02-02 Digital pathology,,"},{"Key":"Keywords","Value":"Homologous recombination,Deep learning,Treatment response,Digital pathology,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>E. N. Bergstrom<\/b><sup>1<\/sup>, A. Abbasi<sup>1<\/sup>, M. Diaz-Gay<sup>1<\/sup>, L. Galland<sup>2<\/sup>, S. Ladoire<sup>2<\/sup>, S. M. Lippman<sup>1<\/sup>, L. B. Alexandrov<sup>1<\/sup>; <br\/><sup>1<\/sup>UC San Diego, San Diego, CA, <sup>2<\/sup>Centre Georges-Fran√ßois Leclerc, Dijon, France","CSlideId":"","ControlKey":"68645416-1af9-4632-af42-51d0a9996999","ControlNumber":"10746","DisclosureBlock":"&nbsp;<b>E. N. Bergstrom, <\/b> None..<br><b>A. Abbasi, <\/b> None..<br><b>M. Diaz-Gay, <\/b> None..<br><b>L. Galland, <\/b> None..<br><b>S. Ladoire, <\/b> None.&nbsp;<br><b>S. M. Lippman, <\/b> <br><b>io9, LLC<\/b> Other, Co-founder and has equity interest. <br><b>L. B. Alexandrov, <\/b> <br><b>io9, LLC<\/b> Other, Compensated consultant and has equity interest. <br><b>Biotheranostics, Inc<\/b> Other, Spouse is an employee.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10356","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"7","PosterboardNumber":"8","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB391","PresenterBiography":null,"PresenterDisplayName":"Erik Bergstrom","PresenterKey":"8f202229-be27-431b-b5ee-9f14cb74e3c0","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB391. Deep learning AI predicts HRD and platinum response from histologic slides","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"592","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Bioinformatics, Computational Biology, Systems Biology, and Convergent Science 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Deep learning AI predicts HRD and platinum response from histologic slides","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++BCS02-02 Digital pathology,,"},{"Key":"Keywords","Value":"Machine learning,Digital Pathology,Pathomics,Gene expression,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>S. S. Sukhadia<\/b><sup>1<\/sup>, D. Yadav<sup>2<\/sup>, K. E. Muller<sup>1<\/sup>; <br\/><sup>1<\/sup>Dartmouth Hitchcock Medical Center, Lebanon, NH, <sup>2<\/sup>Dartmouth College, Lebanon, NH","CSlideId":"","ControlKey":"27b8106f-6808-4493-8e86-dc7b385d82f0","ControlNumber":"10528","DisclosureBlock":"&nbsp;<b>S. S. Sukhadia, <\/b> None..<br><b>D. Yadav, <\/b> None..<br><b>K. E. Muller, <\/b> None.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10357","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"8","PosterboardNumber":"9","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB392","PresenterBiography":null,"PresenterDisplayName":"Shrey Sukhadia, MS","PresenterKey":"c04f3956-681e-4587-9d15-1d40e00a0a3b","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB392. Transformative pathomics in oncology: Harnessing FFPE tissue slide imagery for clinically relevant gene expression prediction in invasive breast carcinoma","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"592","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Bioinformatics, Computational Biology, Systems Biology, and Convergent Science 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Transformative pathomics in oncology: Harnessing FFPE tissue slide imagery for clinically relevant gene expression prediction in invasive breast carcinoma","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++BCS02-06 Liquid biopsy: Multi-analyte and multi-omic,,"},{"Key":"Keywords","Value":"Liquid biopsies,Multiomics,Exosomes,Colorectal cancer,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>K. Manning<\/b><sup>1<\/sup>, D. Miller<sup>1<\/sup>, Y. Yang<sup>1<\/sup>, J. Cole<sup>1<\/sup>, S. Xing<sup>1<\/sup>, C. Benway<sup>1<\/sup>, C. Ray<sup>1<\/sup>, S. Chakrabortty<sup>1<\/sup>, B. Haynes<sup>2<\/sup>, S. Yu<sup>1<\/sup>, J. Skog<sup>1<\/sup>; <br\/><sup>1<\/sup>Exosome Diagnostics, a Bio-techne brand, Waltham, MA, <sup>2<\/sup>Asuragen, a Bio-techne brand, Austin, TX","CSlideId":"","ControlKey":"98a8a5f2-faa0-457e-ab45-cdd5df485607","ControlNumber":"10711","DisclosureBlock":"&nbsp;<b>K. Manning, <\/b> None..<br><b>D. Miller, <\/b> None..<br><b>Y. Yang, <\/b> None..<br><b>J. Cole, <\/b> None..<br><b>S. Xing, <\/b> None..<br><b>C. Benway, <\/b> None..<br><b>C. Ray, <\/b> None..<br><b>S. Chakrabortty, <\/b> None..<br><b>B. Haynes, <\/b> None..<br><b>S. Yu, <\/b> None..<br><b>J. Skog, <\/b> None.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10358","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"9","PosterboardNumber":"10","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB393","PresenterBiography":null,"PresenterDisplayName":"Kyle Manning","PresenterKey":"a1ad5ad3-a02c-4795-839c-ebaf8e38cee7","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB393. Exosome based multiomics combined with cfDNA methylation reveals complementary signatures in blood based liquid biopsy that carry promise for minimally invasive colorectal cancer screening","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"592","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Bioinformatics, Computational Biology, Systems Biology, and Convergent Science 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Exosome based multiomics combined with cfDNA methylation reveals complementary signatures in blood based liquid biopsy that carry promise for minimally invasive colorectal cancer screening","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++BCS02-08 Network biology and precision medicine,,"},{"Key":"Keywords","Value":"Heterogeneity,Hormone receptors,Single cell,Bioinformatics,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>V. N. Kristensen<\/b><sup>1<\/sup>, G. I. G. Alnaes<sup>2<\/sup>, P. Vernhoff<sup>2<\/sup>, L. Schmiester<sup>3<\/sup>, S. Ghannoum<sup>2<\/sup>, M. Fongaard<sup>4<\/sup>, P. M. Bjornstad<sup>2<\/sup>, K. Selsaas<sup>5<\/sup>, S. Geisler<sup>6<\/sup>, M. Seyedzadeh<sup>7<\/sup>, U.-C. Buvarp<sup>6<\/sup>, T. Luders<sup>8<\/sup>, D. Lambrechts<sup>9<\/sup>, M. Lyngra<sup>10<\/sup>, A. Frigessi<sup>3<\/sup>, X. Tekpli<sup>8<\/sup>, J. Geilser<sup>6<\/sup>; <br\/><sup>1<\/sup>University of Oslo, Institute of Clinical Medicine, Faculty of Medicine, Oslo, Norway, <sup>2<\/sup>Oslo University Hospital, Department of Medical Genetics, Oslo, Norway, <sup>3<\/sup>University of Oslo, Oslo Centre for Biostatistics and Epidemiology (OCBE), Oslo, Norway, <sup>4<\/sup>Oslo University Hospital, Depsrtment of Medical Genetics, Oslo, Norway, <sup>5<\/sup>Department of Breast and Endocrine Surgery, Akershus University Hospital, Oslo, Norway, <sup>6<\/sup>Department of Oncology, Akershus University Hospital, Oslo, Norway, <sup>7<\/sup>Department of Radiology, Akershus University Hospital, Oslo, Norway, <sup>8<\/sup>Oslo University Hospital, Institute for Cancer Research, Oslo, Norway, <sup>9<\/sup>Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium, <sup>10<\/sup>Department of Pathology, Akershus University Hospital, Oslo University Hospital, Institute for Cancer Research, Oslo, Norway","CSlideId":"","ControlKey":"f074087a-99d5-4736-9cdb-be73f1e7b4e0","ControlNumber":"10792","DisclosureBlock":"&nbsp;<b>V. N. Kristensen, <\/b> None..<br><b>G. I. G. Alnaes, <\/b> None..<br><b>P. Vernhoff, <\/b> None..<br><b>L. Schmiester, <\/b> None..<br><b>S. Ghannoum, <\/b> None..<br><b>M. Fongaard, <\/b> None..<br><b>P. M. Bjornstad, <\/b> None..<br><b>K. Selsaas, <\/b> None..<br><b>S. Geisler, <\/b> None..<br><b>M. Seyedzadeh, <\/b> None..<br><b>U. Buvarp, <\/b> None..<br><b>T. Luders, <\/b> None..<br><b>D. Lambrechts, <\/b> None..<br><b>M. Lyngra, <\/b> None..<br><b>A. Frigessi, <\/b> None..<br><b>X. Tekpli, <\/b> None..<br><b>J. Geilser, <\/b> None.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10359","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"10","PosterboardNumber":"11","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB394","PresenterBiography":null,"PresenterDisplayName":"Vessela Kristensen, PhD","PresenterKey":"2bf55caa-3096-49d0-bf1d-59c63ebdd474","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB394. <b><\/b>Tumor evolution upon treatment pressure with aromatase inhibitors in locally advanced estrogen receptor positive breast cancer <b><\/b>","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"592","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Bioinformatics, Computational Biology, Systems Biology, and Convergent Science 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"<b><\/b>Tumor evolution upon treatment pressure with aromatase inhibitors in locally advanced estrogen receptor positive breast cancer <b><\/b>","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++BCS02-08 Network biology and precision medicine,,"},{"Key":"Keywords","Value":"Machine learning,,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>B. Qorri<\/b><sup>1<\/sup>, M. J. Tsay<sup>1<\/sup>, P. Leonchyk<sup>1<\/sup>, L. Alphs<sup>2<\/sup>, L. Pani<sup>3<\/sup>, J. Geraci<sup>4<\/sup>; <br\/><sup>1<\/sup>Netramark Corp., Toronto, ON, Canada, <sup>2<\/sup>Larry ALphs, Consulting, Princeton, NJ, <sup>3<\/sup>University of Miami, University of Modena and Reggio Emilia, Miami, FL, <sup>4<\/sup>Queen's University, Kingston, ON, Canada","CSlideId":"","ControlKey":"c3a76c5d-fd13-49ae-8b82-faed262d5316","ControlNumber":"9662","DisclosureBlock":"<b>&nbsp;B. Qorri, <\/b> <br><b>NetraMark<\/b> Employment, Stock Option. <br><b>M. J. Tsay, <\/b> <br><b>NetraMark<\/b> Employment, Stock Option. <br><b>P. Leonchyk, <\/b> <br><b>NetraMark<\/b> Employment, Stock Option. <br><b>L. Alphs, <\/b> <br><b>NetraMark<\/b> Employment, Stock Option. <br><b>L. Pani, <\/b> <br><b>AbbVie, Acadia, Astra-Zeneca, BCG, Boehringer Ingelheim International GmbH, Compass Pathways, EDRA-LSWR Publishing Company, Ferrer, Gedeon-Richter, GLG-Institute, Immunogen, Inpeco, Ipsen<\/b> Other, Scientific Consultant. <br><b>Johnson & Johnson, NeuroCog Trials, Novartis-Gene Therapies, Sanofi-Aventis-Genzyme, NetraMark, Otsuka, Pfizer Global, Relmada Therapeutics, Takeda, Vifor, WCG-VeraSci\/Clinical Endpoint Solutions<\/b> Other, Scientific Consultant. <br><b>Relmada Therapeutics, NetraMark<\/b> Stock, Stock Option. <br><b>J. Geraci, <\/b> <br><b>NetraMark<\/b> Employment, Stock, Stock Option.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10360","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"11","PosterboardNumber":"12","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB395","PresenterBiography":null,"PresenterDisplayName":"Bessi Qorri, PhD","PresenterKey":"b69d6fce-558d-49e9-9172-62b7ed68efda","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB395. NetraAI-driven discovery of novel biomarkers in MSI-high colon cancer for precision immunotherapy","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"592","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Bioinformatics, Computational Biology, Systems Biology, and Convergent Science 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"NetraAI-driven discovery of novel biomarkers in MSI-high colon cancer for precision immunotherapy","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++BCS02-08 Network biology and precision medicine,,"},{"Key":"Keywords","Value":"Machine learning,,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>B. Qorri<\/b><sup>1<\/sup>, M. J. Tsay<sup>1<\/sup>, P. Leonchyk<sup>1<\/sup>, L. Alphs<sup>2<\/sup>, L. Pani<sup>3<\/sup>, J. Geraci<sup>4<\/sup>; <br\/><sup>1<\/sup>Netramark Corp., Toronto, ON, Canada, <sup>2<\/sup>Larry Alphs, Consulting, Princeton, NJ, <sup>3<\/sup>University of Miami; University of Modena and Reggio Emilia, Miami; Modena, FL, <sup>4<\/sup>Queen's University, Kingston, ON, Canada","CSlideId":"","ControlKey":"0fe35526-abbd-4305-b7e2-0318491f90d3","ControlNumber":"9708","DisclosureBlock":"<b>&nbsp;B. Qorri, <\/b> <br><b>NetraMark<\/b> Employment, Stock Option. <br><b>M. J. Tsay, <\/b> <br><b>NetraMark<\/b> Employment, Stock Option. <br><b>P. Leonchyk, <\/b> <br><b>NetraMark<\/b> Employment, Stock Option. <br><b>L. Alphs, <\/b> <br><b>NetraMark<\/b> Employment, Stock Option. <br><b>L. Pani, <\/b> <br><b>AbbVie, Acadia, Astra-Zeneca, BCG, Boehringer Ingelheim International GmbH, Compass Pathways, EDRA-LSWR Publishing Company, Ferrer, Gedeon-Richter, GLG-Institute, Immunogen, Inpeco, Ipsen<\/b> Other, Scientific Consultant. <br><b>Johnson & Johnson, NeuroCog Trials, Novartis-Gene Therapies, Sanofi-Aventis-Genzyme, NetraMark, Otsuka, Pfizer Global, Relmada Therapeutics, Takeda, Vifor, WCG-VeraSci\/Clinical Endpoint Solutions<\/b> Other, Scientific Consultant. <br><b>Relmada Therapeutics, NetraMark<\/b> Stock, Stock Option. <br><b>J. Geraci, <\/b> <br><b>NetraMark<\/b> Employment, Stock, Stock Option.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10361","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"12","PosterboardNumber":"13","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB396","PresenterBiography":null,"PresenterDisplayName":"Bessi Qorri, PhD","PresenterKey":"b69d6fce-558d-49e9-9172-62b7ed68efda","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB396. The power of NetraAI: Precision medicine in oncology through sub-insight learning from small data sets","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"592","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Bioinformatics, Computational Biology, Systems Biology, and Convergent Science 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"The power of NetraAI: Precision medicine in oncology through sub-insight learning from small data sets","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++BCS02-10 Other,,"},{"Key":"Keywords","Value":"CRISPR\/Cas9,Ionizing radiation,DNA double-strand break,Chromosomal instability,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>S. K. Teh<\/b>, A. Kotwal, E. Halper-Stromberg, L. Morsberger, K. Bowland, A. Bennett, M. Goldstein, Y. S. Zou, J. R. Eshleman; <br\/>Johns Hopkins University School of Medicine, Baltimore, MD","CSlideId":"","ControlKey":"511ac5ee-21a0-48c7-a3a8-1457b36e95f2","ControlNumber":"10823","DisclosureBlock":"&nbsp;<b>S. K. Teh, <\/b> None..<br><b>A. Kotwal, <\/b> None..<br><b>E. Halper-Stromberg, <\/b> None..<br><b>L. Morsberger, <\/b> None..<br><b>K. Bowland, <\/b> None..<br><b>A. Bennett, <\/b> None..<br><b>M. Goldstein, <\/b> None..<br><b>Y. S. Zou, <\/b> None..<br><b>J. R. Eshleman, <\/b> None.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10362","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"13","PosterboardNumber":"14","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB397","PresenterBiography":null,"PresenterDisplayName":"Selina Shiqing Teh, BS,PhD","PresenterKey":"12b46e6a-7d58-4042-8ed0-b142138df8b2","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB397. Simultaneous CRISPR-Cas9 induced double strand breaks causes chromosomal catastrophe in pancreatic cancers: A parallel comparison with ionizing radiation","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"592","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Bioinformatics, Computational Biology, Systems Biology, and Convergent Science 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Simultaneous CRISPR-Cas9 induced double strand breaks causes chromosomal catastrophe in pancreatic cancers: A parallel comparison with ionizing radiation","Topics":null,"cSlideId":""}]